The rationale and evidence base for a protective role of macular pigment in age-related maculopathy.
about
VEGF-targeted therapy and beyond: pharmacotherapy and emerging treatments in agerelated macular degeneration.Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.Retinal light toxicityMacular pigment optical density measurements by one-wavelength reflection photometry--influence of cataract surgery on the measurement results.Recovery of macular pigment spectrum in vivo using hyperspectral image analysis.Multispectral retinal image analysis: a novel non-invasive tool for retinal imaging.REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.Downregulating p22phox ameliorates inflammatory response in Angiotensin II-induced oxidative stress by regulating MAPK and NF-κB pathways in ARPE-19 cellsRetinal spectral domain optical coherence tomography in early atrophic age-related macular degeneration (AMD) and a new metric for objective evaluation of the efficacy of ocular nutritionCognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent CarotenoidsOverall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial.Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids.Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT)The heritability of the ring-like distribution of macular pigment assessed in a twin studyThe role of epigenetics in age-related macular degeneration.Macular pigment and macular volume in eyes of patients with cystic fibrosis.Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration.Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration.Evaluation of ultraviolet light toxicity on cultured retinal pigment epithelial and retinal ganglion cells.Macular pigment and its contribution to visual performance and experience.Changes in macular pigment optical density and serum concentrations of lutein and zeaxanthin in response to weight loss.The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample.Changes of macular pigment optical density in elderly eyes: a longitudinal analysis from the MARS study.Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.
P2860
Q34081923-01FAAA3C-564B-4340-9E06-020C1008DEE9Q34108927-2A3A9415-9E33-44F6-BD70-6D90CA28D1D5Q34315578-9CCB9530-2254-4234-9CFA-EACED169749DQ35130887-6CCB6ED4-6BB9-4DB3-9A8C-C63E213426C2Q35154311-4CF814C4-CDFB-48F3-8FA6-1C61B2C55968Q35510105-CDE7467F-383A-455B-83E1-1D76B7ED3748Q35603511-5A1BD2EB-5897-475E-A685-69010A167363Q35865877-14C4B7B3-8404-498C-A3A9-9EA79564E1BBQ36101886-672EC332-4C91-4B70-91C0-50FAF6FD40AAQ36538104-9F1A3BB5-BB94-4BEB-B77A-3AFA2CA875BCQ37044220-5D9EB75D-0728-41D5-8A65-90490DEE9DF0Q37338182-E1B6C175-7349-4CC2-87BB-458580C8C54BQ37625442-1BF754D2-C673-48E4-A381-1A5D21E57066Q37631347-AB58DB9A-77D2-49D6-9B8B-A05F5D6626F9Q37691939-29EC2414-FF8D-45C8-98AE-D738556FC66EQ38252350-B2392813-8D4F-42AF-B959-BFDBA5856831Q39231679-968ABE25-1A88-433E-924D-7490BB21B022Q39436968-1ABB96DC-8DDB-49E3-A944-71366C3F5523Q41002492-42315F60-8A10-46DA-8736-EA9CA0262ABEQ42080972-D0E92EB5-4F07-40F4-9A84-06DFC52914E9Q46305501-4CEF77D9-79C5-49DB-BAB8-40AD6847435BQ47401647-4B2D6F36-3AC7-4CFF-B9BB-7609B77D59DAQ47418164-57305A19-674E-4044-BE26-209A57866A2AQ51064539-88C960FC-3393-44F1-A888-F901A95E4007Q54571267-995F60DB-7E97-43FF-85CE-8B5291B8A175
P2860
The rationale and evidence base for a protective role of macular pigment in age-related maculopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The rationale and evidence bas ...... nt in age-related maculopathy.
@en
The rationale and evidence bas ...... nt in age-related maculopathy.
@nl
type
label
The rationale and evidence bas ...... nt in age-related maculopathy.
@en
The rationale and evidence bas ...... nt in age-related maculopathy.
@nl
prefLabel
The rationale and evidence bas ...... nt in age-related maculopathy.
@en
The rationale and evidence bas ...... nt in age-related maculopathy.
@nl
P2093
P356
P1476
The rationale and evidence bas ...... ent in age-related maculopathy
@en
P2093
P304
P356
10.1136/BJO.2007.135566
P407
P50
P577
2008-07-31T00:00:00Z